Treatment of imported severe malaria with artesunate instead of quinine - more evidence needed?
Open Access
- 7 September 2011
- journal article
- Published by Springer Nature in Malaria Journal
- Vol. 10 (1), 256
- https://doi.org/10.1186/1475-2875-10-256
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Indolone-N-oxide derivatives: in vitro activity against fresh clinical isolates of Plasmodium falciparum, stage specificity and in vitro interactions with established antimalarial drugsJournal of Antimicrobial Chemotherapy, 2011
- Intravenous Artesunate for Severe Malaria in Travelers, EuropeEmerging Infectious Diseases, 2011
- Dose‐Dependent Risk of Neutropenia after 7‐Day Courses of Artesunate Monotherapy in Cambodian Patients with AcutePlasmodium falciparumMalariaClinical Infectious Diseases, 2010
- Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trialThe Lancet, 2010
- Severe Imported Falciparum Malaria: A Cohort Study in 400 Critically Ill AdultsPLOS ONE, 2010
- Toxicity of the antimalarial artemisinin and its dervativesCritical Reviews in Toxicology, 2010
- Artemisinin Resistance inPlasmodium falciparumMalariaNew England Journal of Medicine, 2009
- Evidence of Artemisinin-Resistant Malaria in Western CambodiaNew England Journal of Medicine, 2008
- Artesunate versus quinine for treating severe malariaPublished by Wiley ,2006
- Antimalarial Drugs Reduce Cytoadherence and Rosetting of Plasmodium falciparumThe Journal of Infectious Diseases, 1996